Title: Anthropic Expands AI Portfolio as Policy Shifts

01Anthropic Launches Claude Science to Bring Autonomous AI Agents to Scientific Research

Anthropic has announced Claude Science, a major new product intended to support scientific research in the same way that Claude Code supports software engineering. The announcement was made at an event for pharmaceutical executives, biotech founders, and researchers on Tuesday. Like Claude Code, Claude Science can autonomously carry out meaningful work when given concise, high-level instructions.

The platform functions as a workbench that gives scientists one environment to do computational research, saving them from the need to bounce between databases, pipelines, and tools. Rather than introducing a new model, Anthropic is betting that improved workflow integration will win over scientists who need AI assistance for complex research tasks.

02Anthropic Releases Claude Sonnet 5 with Near-Opus Performance at Lower Cost

Anthropic has launched Claude Sonnet 5 with stronger agentic capabilities, lower pricing, and improved safety. The model delivers performance approaching Opus 4.8 levels while positioning itself as a cheaper alternative to Opus, GPT-5.5, and Gemini Pro.

The release intensifies competition in the AI model market by offering near-top-tier capabilities at significantly reduced costs. This pricing strategy could reshape enterprise purchasing decisions as organizations seek to balance performance with budget constraints.

03Trump Administration Reverses Course, Lifts Export Controls on Anthropic's Mythos and Fable Models

The White House is easing restrictions on Anthropic's most advanced AI models weeks after ordering the company to suspend access for foreign nationals. The reversal signals a shift in the administration's approach to AI export policy.

The policy change removes barriers that had limited international access to Anthropic's Mythos and Fable models, potentially expanding the company's global market reach.


Also today

ShareXLinkedIn